Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

[11C]NNC 12-0722 or [18F]GBR 13119: Just what is “better”?

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Muller L, Halldin C, Foged C, Karlsson P, Hall H, Swahn C-G, Suzdak PD, Hohlweg R, Nielsen EB, Farde L. Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. Eur J Nucl Med 1994;21: 131–137.

  2. 2.

    Kilbourn MR, Carey JE, Koeppe RE, Haka MS, Hutchins GD, Sherman PS, Kuhl DE. Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. Nucl Med Biol 1989;16: 569–576.

  3. 3.

    Ciliax BJ, Kilbourn MR, Haka MS, Penney JB Jr. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain. J Neurochem 1990;55: 619–623.

  4. 4.

    Koeppe RA, Kilbourn MR, Frey KA, Penney JB, Haka MS, Kuhl DE. Imaging and kinetic modeling of [F-18]GBR 12909, a dopamine uptake inhibitor [abstract]. J Nucl Med 1990;31: 720.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kilbourn, M.R. [11C]NNC 12-0722 or [18F]GBR 13119: Just what is “better”?. Eur J Nucl Med 21, 695 (1994). https://doi.org/10.1007/BF00285593

Download citation

Keywords

  • Public Health
  • Nuclear Medicine